NCT03229564View on ClinicalTrials.gov

Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Children

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 25, 2017

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2028

Conditions
Burns
Interventions
BIOLOGICAL

EHSG-KF

Transplantation of autologous dermo-epidermal skin substitute EHSG-KF to the experimental area

BIOLOGICAL

STSG

Transplantation of autologous split-thickness skin graft to the control area

Trial Locations (4)

1940

Rode Kruis Ziekenhuis, Beverwijk

8032

University Children's Hospital Zurich, Zurich

Unknown

Dipartimento di Chirurgia Pediatrica Ospedale dei bambini Vittorio Buzzi, Milan

Unità di Chirurgia Plastica e Ustioni Ospedale Santobono, Napoli

Sponsors

Collaborators (1)

Julius Clinical
All Listed Sponsors
collaborator

Wyss Zurich

UNKNOWN

collaborator

Julius Clinical

INDUSTRY

collaborator

Sintesi Research Srl

INDUSTRY

collaborator

University Hospital, Zürich

OTHER

collaborator

University of Zurich

OTHER

lead

CUTISS AG

INDUSTRY

NCT03229564 - Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Children | Biotech Hunter | Biotech Hunter